Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy.

Magnetic resonance imaging Prostate cancer Robot-assisted radical prostatectomy Urethral length Urinary continence

Journal

Prostate international
ISSN: 2287-8882
Titre abrégé: Prostate Int
Pays: Korea (South)
ID NLM: 101605566

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 29 03 2018
revised: 18 05 2018
accepted: 18 06 2018
entrez: 7 8 2019
pubmed: 7 8 2019
medline: 7 8 2019
Statut: ppublish

Résumé

To determine the clinical predictive factors affecting the recovery from postoperative urinary incontinence after robot-assisted radical prostatectomy (RARP). We consecutively analyzed 320 patients who underwent RARP between January 2012 and March 2015. The restoration of urinary continence was defined as follows: the use of no pads/no leakage of urine or the use of a safety pad. Preoperative covariates were statistically assessed by multivariate logistic regression analysis to investigate their predict factor to recovery of urinary incontinence. Therefore, in this study, we sought to identify predictors of early urinary continence status in a single-center retrospective study of consecutive patients who underwent RARP. Continence rates at 1, 3, 6, and 12 months after the catheter was removed were 44%, 71%, 83%, and 93%, respectively. Age, body mass index, and prostate volume had no significant association with urinary continence recovery. In contrast to this, longer preoperative membranous urethral length (MUL) was significantly associated with earlier postoperative continence recovery. Multivariate analysis demonstrated that longer preoperative MUL is significantly associated with continence recovery at 1 month ( Approximately 70% of patients achieved urinary continence within 3 months after RARP. Multivariate analysis showed that age, body mass index, and prostate volume had no significant association with urinary continence recovery. Preoperative MUL assessed by magnetic resonance imaging was an independent predictor of early recovery from urinary incontinence after RARP.

Identifiants

pubmed: 31384606
doi: 10.1016/j.prnil.2018.06.003
pii: S2287-8882(18)30046-1
pmc: PMC6664308
doi:

Types de publication

Journal Article

Langues

eng

Pagination

54-59

Références

Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
J Urol. 2002 Sep;168(3):1032-5
pubmed: 12187216
J Urol. 2003 Jun;169(6):2225-8
pubmed: 12771755
Urology. 2004 Dec;64(6):1224-8
pubmed: 15596205
Urology. 2007 Feb;69(2):300-5
pubmed: 17320668
J Urol. 2008 May;179(5):1907-11
pubmed: 18353395
J Urol. 2008 Sep;180(3):928-32
pubmed: 18635217
Eur Urol. 2009 Mar;55(3):629-37
pubmed: 18801612
Eur Urol. 2009 Jun;55(6):1358-66
pubmed: 19147274
Eur Urol. 2009 Sep;56(3):472-8
pubmed: 19560260
BJU Int. 2009 Nov;104(10):1492-5
pubmed: 19583731
J Endourol. 2009 Sep;23(9):1443-50
pubmed: 19698020
Urology. 2010 Feb;75(2):431-6
pubmed: 19854484
Urol Clin North Am. 1991 May;18(2):211-27
pubmed: 2017805
Urology. 2010 Nov;76(5):1117-21
pubmed: 20708781
Eur Urol. 2010 Nov;58(5):687-700
pubmed: 20727668
BJU Int. 2011 Nov;108(9):1492-6
pubmed: 21244602
J Urol. 2012 Feb;187(2):569-74
pubmed: 22177170
J Urol. 2012 Mar;187(3):945-50
pubmed: 22264458
Eur Urol. 2012 Sep;62(3):405-17
pubmed: 22749852
Eur Urol. 2013 Mar;63(3):438-44
pubmed: 22901982
Neurourol Urodyn. 2013 Sep;32(7):957-63
pubmed: 23371847
Int J Urol. 2013 Nov;20(11):1052-63
pubmed: 23841851
Neurourol Urodyn. 2015 Aug;34(6):527-32
pubmed: 24752967
Urology. 2014 Jul;84(1):144-8
pubmed: 24785988
World J Urol. 2015 Jun;33(6):771-9
pubmed: 24928375
Can Urol Assoc J. 2015 Jan-Feb;9(1-2):e93-7
pubmed: 25737770
Int J Med Robot. 2016 Sep;12(3):496-501
pubmed: 26097204
Eur Urol. 2016 Mar;69(3):485-95
pubmed: 26297603
J Robot Surg. 2016 Sep;10(3):187-200
pubmed: 27251473
Eur Urol. 2017 Mar;71(3):368-378
pubmed: 27394644
J Urol. 2017 Jan;197(1):109-114
pubmed: 27475967
BJU Int. 2017 Oct;120(4):520-529
pubmed: 28425193

Auteurs

Kosuke Kitamura (K)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Toshiyuki China (T)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Mayuko Kanayama (M)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Masayosi Nagata (M)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Shuji Isotani (S)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Yoshiaki Wakumoto (Y)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Satoru Muto (S)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
Department of Advanced Informatics for Genetic Disease, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Hisamitsu Ide (H)

Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

Shigeo Horie (S)

Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.

Classifications MeSH